No abstract

Objective: Adolescents with polycystic ovary syndrome (PCOS) and obesity can have insulin resistance, dysglycemia, and hepatic steatosis. Excess pancreatic fat may disturb insulin secretion and relate to hepatic fat. Associations between pancreatic fat fraction (PFF) and metabolic measures in PCOS were unknown. Methods:This secondary analysis included 113 sedentary, nondiabetic adolescent girls (age = 15.4 [1.9] years), with or without PCOS and BMI ≥ 90th percentile.Participants underwent fasting labs, oral glucose tolerance tests, and magnetic resonance imaging for hepatic fat fraction (HFF) and PFF. Groups were categorized by PFF (above or below the median of 2.18%) and compared.Results: Visceral fat and HFF were elevated in individuals with PCOS versus control individuals, but PFF was similar. PFF did not correlate with serum androgens. Higher and lower PFF groups had similar HFF, with no correlation between PFF and HFF, although hepatic steatosis was more common in those with higher PFF (≥5.0% HFF; 60% vs. 36%; p = 0.014). The higher PFF group had higher fasting insulin (p = 0.026), fasting insulin resistance (homeostatic model assessment of insulin resistance, p = 0.032; 1/fasting insulin, p = 0.028), free fatty acids (p = 0.034), and triglycerides (p = 0.004) compared with those with lower PFF. β-Cell function and insulin sensitivity were similar between groups. Conclusions:Neither PCOS status nor androgens related to PFF. However, fasting insulin and postprandial lipids were worse with higher PFF.Data are presented as mean ± SD or median and interquartile range (25th, 75th). Impaired fasting glucose is >90 mg/dL. Impaired glucose tolerance is ≥140 mg/dL at 2 hours post glucose load in the OGTT. Prediabetes is HbA1c between 5.7% and 6.4% or impaired fasting glucose (glucose > 90 mg/dL) or impaired glucose tolerance (glucose ≥ 140 mg/dL at 2 hours post glucose load in the OGTT).Abbreviations: HbA1c, hemoglobin A1c; HOMA-IR, homeostatic model assessment of insulin resistance; ISSI-2, insulin secretion-sensitivity index-2; OMM, oral minimal model; PFF, pancreatic fat fraction; Si, insulin sensitivity; WBISI, whole-body insulin sensitivity index. a Excludes participants taking exenatide (n = 8).b n = 66.

Background/objective: Rates of dysglycemia are increasing in youth, secondary to obesity and decreased insulin sensitivity (IS) in puberty. The oral minimal model (OMM) has been developed in order to measure IS using an easy oral glucose load, such as an oral glucose tolerance test (OGTT), instead of an hyperinsulinemiceuglycemic clamp (HE-clamp), a more invasive and time-consuming procedure. However, this model, following a standard 2 hour-OGTT has never been validated in youth, a population known for a different physiologic response to OGTT than adults. Thus, we compared IS measurements obtained from OMM following a 2-hour OGTT to HE-clamp and isotope tracer-assessed tissue IS in adolescents. We also compared the liver/muscle-specific IS from HE-clamp with other liver/muscle-specific IS surrogates following an OGTT previously validated in adults. Methods: Secondary analysis of a cross-sectional study. Adolescent girls with (n = 26) and without (n = 7) polycystic ovary syndrome (PCOS) (14.6 ± 1.7 years; BMI percentile 23.3%-98.2%) underwent a 2-hour 75 g OGTT and a 4-phase HE-clamp. OMM IS (Si), dynamic Si (Si d) and other OGTT-derived muscle and liver IS indices were correlated with HE-clamp tissue-specific IS.

Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder which develops in adolescence and affects 6-10% of women. PCOS is associated with insulin resistance (IR), which can occur in multiple tissues, in particular skeletal muscle and liver. Reliable assessment of tissue-specific IR in youth with PCOS is important for development of new therapies. The gold-standard method to assess tissue-IR is the hyper-insulinemic euglycemic clamp, a method which is too intensive for use in routine research. We aimed to validate surrogate indices (the oral minimal model (OMM)-derived whole-body index and the Abdul-Ghani model-derived muscle index and liver index) against their respective clamp measurements in a population of high-IR-risk adolescent girls. 45 adolescent girls (14.6 ± 1.7 years; BMI %ile 23.3%-98.2%) underwent a standard 2-hour oral glucose tolerance test (OGTT) (75g glucose) and a multi-phase hyper-insulinemic euglycemic clamp (10,16 and 80 mU/m 2 /min) with a glucose isotope tracer. This study was a secondary analysis. OMM total Si was computed using SAAM II software, using 0, 15, 30, 60, 90, 120 min time points and the assumption that glucose rate of appearance (Ra) decays exponentially after 120 min. Abdul-Ghani muscle and liver insulin resistance indices (IRIs) were calculated: liver IRI= AUC 0-30min Glucose (mmol L -1 min) x AUC 0-30min Insulin (pmol L -1 min); muscle IRI= mean insulin 0-120min . Correlation analyses were performed using Spearman’s or Pearson’s correlation, as appropriate. OMM total Si correlated with clamp-measured insulin sensitivity (glucose infusion rate, r=0.65; p<0.0001), whereas muscle IRI did not (p=0.45). Liver IRI correlated moderately with clamp-derived hepatic insulin sensitivity (insulin concentration required to suppress 50% of basal endogenous glucose production; r=0.35; p=0.03). In adolescent girls at high risk of IR, OMM provided a strong surrogate characterization of whole-body IR when evaluated against the clamp. The Abdul-Ghani model indices are simpler to calculate compared to OMM; however, these results suggest that the Abdul-Ghani indices may not be adequate for describing and distinguishing among individuals within a narrower IR range, such as that found in our study population. By contrast, OMM offers an effective, OGTT-based methodology to be used in research studies for characterizing whole-body IR that is less resource-intensive compared to the clamp. Future work is needed to determine if the sensitivity of this model can be further improved with a longer-duration OGTT as obese youth can have an exaggerated and prolonged response to an OGTT. Funding: Thrasher Research Foundation, AHA CRP, Endocrine Society Fellowship in Women's Health, NIDDK K23

No abstract